Pure Biologics S.A.: directors' dealings · Poland · KNF KNF:pure-biologics-sa PL PL · KNF Mcap 26M€
Explore the full management transaction log of Pure Biologics S.A., a listed issuer based in Poland. Shares trade on PL PL, under the oversight of KNF. Market capitalisation: €26.1m. The latest transaction was reported on 18 May 2026 — Notification PDMR. Among the most active insiders: Anonymous (PDMR). All data is openly available.
Financial data FY ended December 2024 · cache
Income statement
Gross profit −46 k€
Net income −19.4 M€ 0.0% margin
Balance sheet & cash
Market cap 26.1 M€
Total debt 14.1 M€
Free Cash Flow −10.8 M€
Profitability & ownership
ROA -116.3%
% insiders 28.1%
% institutions 0.5%
Last declaration on 18 May 2026
Declarations 8 total
Executives ● Notification PDMR0 KNF
KNF:node/536405 · 18 May 2026 details not loaded
Executives ● Notification PDMR0 KNF
KNF:node/522233 · 18 May 2026 details not loaded
Executives ● Notification PDMR0 KNF
KNF:node/560242 · 18 May 2026 details not loaded
Executives ● Notification PDMR0 KNF
KNF:node/546909 · 18 May 2026 details not loaded
Executives ● Notification PDMR0 KNF
KNF:node/519807 · 18 May 2026 details not loaded
Executives ● Notification PDMR0 KNF
KNF:node/543090 · 18 May 2026 details not loaded
Executives ● Notification PDMR0 KNF
KNF:node/540127 · 18 May 2026 details not loaded
Executives ● Notification PDMR0 KNF
KNF:node/519062 · 18 May 2026 details not loaded